Death is associated to the type of drug-eluting stent in patients with left ventricular dysfunction and elevated natriuretic peptide levels
Abstract As advanced heart failure (HF) with elevated NT-proBNP is characterized by an activated coagulation system, coronary events clinically noticed as sudden or HF death may be more common after treatment with first- compared to newer-generation DES. Our study evaluates (1) if patients with left...
Guardado en:
Autores principales: | Christian Roth, Clemens Gangl, Walter S. Speidl, Georg Goliasch, Matthias Schneider, Daniel Dalos, Rudolf Berger |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/0c8ae0d5ccd840b382c9f9eb0f930b19 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Everolimus-eluting coronary stents
por: Alejandro Saez, et al.
Publicado: (2010) -
Subclinical Left Ventricular Dysfunction During Chemotherapy
por: Martin Nicol, et al.
Publicado: (2019) -
Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Piotr Desperak, et al.
Publicado: (2020) -
Very Long-term Safety and Effectiveness of Drug-Eluting or Bare-Metal Stents for Left Main Coronary Disease
por: Hanbit Park, MD, et al.
Publicado: (2021) -
Computational and experimental mechanical performance of a new everolimus-eluting stent purpose-built for left main interventions
por: Saurabhi Samant, et al.
Publicado: (2021)